ID27788A - Peptida-peptida antigen tumor yang diperoleh dari siklofilin b - Google Patents
Peptida-peptida antigen tumor yang diperoleh dari siklofilin bInfo
- Publication number
- ID27788A ID27788A IDW20002735A ID20002735A ID27788A ID 27788 A ID27788 A ID 27788A ID W20002735 A IDW20002735 A ID W20002735A ID 20002735 A ID20002735 A ID 20002735A ID 27788 A ID27788 A ID 27788A
- Authority
- ID
- Indonesia
- Prior art keywords
- cyclophilins
- tumor
- cyclefilin
- antigenal
- derivatives
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 102000001493 Cyclophilins Human genes 0.000 abstract 4
- 108010068682 Cyclophilins Proteins 0.000 abstract 4
- 239000000427 antigen Substances 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17844998 | 1998-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID27788A true ID27788A (id) | 2001-04-26 |
Family
ID=16048723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002735A ID27788A (id) | 1998-06-25 | 1999-06-24 | Peptida-peptida antigen tumor yang diperoleh dari siklofilin b |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7041297B1 (id) |
| EP (1) | EP1090924B8 (id) |
| JP (1) | JP4413429B2 (id) |
| KR (1) | KR100653590B1 (id) |
| CN (1) | CN1318447C (id) |
| AT (1) | ATE375362T1 (id) |
| AU (1) | AU749544B2 (id) |
| CA (1) | CA2331761A1 (id) |
| DE (1) | DE69937294T2 (id) |
| ES (1) | ES2294844T3 (id) |
| HK (1) | HK1067645A1 (id) |
| ID (1) | ID27788A (id) |
| NZ (1) | NZ508996A (id) |
| TW (1) | TWI228128B (id) |
| WO (1) | WO1999067288A1 (id) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105306B1 (en) * | 2000-08-10 | 2006-09-12 | Trustees Of The University Of Pennsylvania | Methods and compositions for modulating somatolactogenic functions |
| AU7652000A (en) * | 1999-09-10 | 2001-04-17 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Ant-1 as drug target |
| JP2003523963A (ja) | 2000-01-24 | 2003-08-12 | トラスティーズ・オブ・タフツ・カレッジ | クリプトスポリジウム・パルヴム関連疾患の治療のためのテトラサイクリン化合物 |
| AU2001259701A1 (en) * | 2000-05-15 | 2001-11-26 | Paratek Pharmaceuticals, Inc | 7-substituted fused ring tetracycline compounds |
| AU2001268475A1 (en) * | 2000-06-16 | 2002-01-02 | Trustees Of Tufts College | 7-phenyl-substituted tetracycline compounds |
| AU2002365120A1 (en) * | 2001-08-02 | 2003-07-15 | Paratek Pharmaceuticals, Inc. | Medicaments |
| EP2267021B1 (en) | 2002-09-12 | 2015-02-18 | Oncotherapy Science, Inc. | KDR peptides and vaccines comprising the same |
| CA2538300A1 (en) * | 2003-09-22 | 2005-03-31 | Green Peptide Co., Ltd. | Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent |
| TWI261038B (en) * | 2004-08-11 | 2006-09-01 | Bo-Cheng Chen | Bicycle gear-shifting handgrip |
| EP1805134B1 (en) | 2004-10-25 | 2012-06-20 | Paratek Pharmaceuticals, Inc. | 4-aminotetracyclines and methods of use thereof |
| AU2007244153C1 (en) | 2006-05-01 | 2011-09-29 | Hitachi Chemical Company, Ltd. | Prostasin partial peptide and anti-prostasin antibody |
| US8440646B1 (en) | 2006-10-11 | 2013-05-14 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of Bacillus anthracis infections |
| JP2010512730A (ja) | 2006-12-13 | 2010-04-30 | オンコセラピー・サイエンス株式会社 | 肺癌の腫瘍マーカーおよび治療標的としてのｔｔｋ |
| CA2678432A1 (en) | 2007-02-16 | 2008-08-21 | Oncotherapy Science, Inc. | Vaccine therapy for choroidal neovascularization |
| TW201425333A (zh) | 2007-04-11 | 2014-07-01 | Oncotherapy Science Inc | 腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗 |
| CN101835893A (zh) | 2007-08-24 | 2010-09-15 | 肿瘤疗法科学股份有限公司 | 癌症相关基因cdca5、epha7、stk31和wdhd1 |
| KR101512885B1 (ko) | 2007-09-18 | 2015-04-16 | 가부시키가이샤 그린 펩티드 | Ｃｔｌ 유도제 조성물 |
| RU2483072C2 (ru) | 2007-11-29 | 2013-05-27 | Актелион Фармасьютиклз Лтд | Производные фосфоновой кислоты и их применение в качестве антагонистов рецептора p2y12 |
| TWI526219B (zh) | 2008-06-19 | 2016-03-21 | 腫瘤療法 科學股份有限公司 | Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗 |
| DE102008060549A1 (de) | 2008-12-04 | 2010-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung |
| TWI500932B (zh) | 2008-12-05 | 2015-09-21 | Oncotherapy Science Inc | Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗 |
| TWI469791B (zh) | 2009-02-18 | 2015-01-21 | Oncotherapy Science Inc | Ｆｏｘｍ１胜肽以及含此胜肽之疫苗 |
| DK2408913T3 (en) | 2009-03-18 | 2017-03-06 | Oncotherapy Science Inc | NEIL3 PEPTIDES AND VACCINES CONTAINING THESE |
| TWI507204B (zh) | 2009-05-26 | 2015-11-11 | Oncotherapy Science Inc | Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗 |
| TW201136604A (en) | 2009-12-14 | 2011-11-01 | Oncotherapy Science Inc | TMEM22 peptides and vaccines including the same |
| CA2792910A1 (en) | 2010-03-11 | 2011-09-15 | Yusuke Nakamura | Hjurp peptides and vaccines including the same |
| ES2613808T3 (es) | 2011-07-29 | 2017-05-26 | Oncotherapy Science, Inc. | Péptido derivado de ERAP1 y uso del mismo |
| KR102015648B1 (ko) | 2011-08-12 | 2019-08-28 | 온코세라피 사이언스 가부시키가이샤 | Ｍｐｈｏｓｐｈ１ 펩티드 및 이를 포함한 백신 |
| SG10201608552WA (en) | 2011-10-28 | 2016-12-29 | Oncotherapy Science Inc | Topk Peptides And Vaccines Including The Same |
| JP6255594B2 (ja) | 2012-07-10 | 2018-01-10 | オンコセラピー・サイエンス株式会社 | Ｔｈ１細胞のＬＹ６Ｋエピトープペプチドおよびこれを含有するワクチン |
| EP2872530A4 (en) | 2012-07-10 | 2016-04-06 | Oncotherapy Science Inc | KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME |
| DK2895600T3 (da) | 2012-09-11 | 2020-04-27 | Onco Therapy Science Inc | Ube2t-peptider og vacciner, der indeholder disse |
| TWI658049B (zh) | 2013-03-12 | 2019-05-01 | 腫瘤療法 科學股份有限公司 | Ｋｎｔｃ２胜肽及含此胜肽之疫苗 |
| JP6211093B2 (ja) | 2013-10-21 | 2017-10-11 | 大鵬薬品工業株式会社 | 新規ｃｔｌエピトープ４連結ペプチド |
| BR112017002193A2 (pt) | 2014-08-04 | 2017-11-21 | Oncotherapy Science Inc | peptídeo derivado de urlc10 e vacina contendo o mesmo |
| CN113321704A (zh) | 2014-08-04 | 2021-08-31 | 肿瘤疗法科学股份有限公司 | Cdca1衍生的肽和含有它们的疫苗 |
| EP3981416B1 (en) | 2014-08-04 | 2024-03-20 | OncoTherapy Science, Inc. | Koc1-derived peptide and vaccine including same |
| US11242365B2 (en) | 2015-10-08 | 2022-02-08 | Oncotherapy Science, Inc. | FOXM1-derived peptide, and vaccine including same |
| US20210236613A1 (en) | 2018-06-29 | 2021-08-05 | Taiho Pharmaceutical Co., Ltd. | Antitumor agent and evaluation method thereof |
| TW202023581A (zh) | 2018-08-02 | 2020-07-01 | 日商腫瘤療法 科學股份有限公司 | 來自cdca1的胜肽及含有此的疫苗 |
| US20220098256A1 (en) | 2018-11-30 | 2022-03-31 | Tokushima University | Therapeutic agent for breast cancer comprising big3-phb2 interaction-inhibiting peptide derived from phb2 |
| KR20220120627A (ko) | 2019-12-26 | 2022-08-30 | 다이호야쿠힌고교 가부시키가이샤 | 수술 후 보조 요법제 |
| DE102022118517A1 (de) | 2022-07-25 | 2024-01-25 | Dennis Reitmeir | Liegestützvorrichtung mit drehbaren Griffeinheiten |
| CN115372618A (zh) * | 2022-09-19 | 2022-11-22 | 首都医科大学附属北京胸科医院 | 一种检测蛋白标志物水平的试剂在制备用于评估肿瘤治疗效果的诊断产品中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0326067A3 (en) * | 1988-01-26 | 1991-04-17 | The Du Pont Merck Pharmaceutical Company | Use of cyclophilin as an anti-inflammatory and immunomodulatory agent |
| EP0656788B1 (en) * | 1992-08-07 | 2006-10-18 | Pharmexa Inc. | Hla binding peptides and their uses |
| JPH09151200A (ja) * | 1995-09-29 | 1997-06-10 | Ajinomoto Co Inc | ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤 |
| US5840839A (en) * | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
-
1999
- 1999-06-24 US US09/720,469 patent/US7041297B1/en not_active Expired - Fee Related
- 1999-06-24 CN CNB998098566A patent/CN1318447C/zh not_active Expired - Lifetime
- 1999-06-24 CA CA002331761A patent/CA2331761A1/en not_active Abandoned
- 1999-06-24 ID IDW20002735A patent/ID27788A/id unknown
- 1999-06-24 ES ES99926783T patent/ES2294844T3/es not_active Expired - Lifetime
- 1999-06-24 KR KR1020007014760A patent/KR100653590B1/ko not_active IP Right Cessation
- 1999-06-24 JP JP2000555939A patent/JP4413429B2/ja not_active Expired - Lifetime
- 1999-06-24 WO PCT/JP1999/003360 patent/WO1999067288A1/ja active IP Right Grant
- 1999-06-24 AU AU43926/99A patent/AU749544B2/en not_active Ceased
- 1999-06-24 AT AT99926783T patent/ATE375362T1/de not_active IP Right Cessation
- 1999-06-24 NZ NZ508996A patent/NZ508996A/en unknown
- 1999-06-24 DE DE69937294T patent/DE69937294T2/de not_active Expired - Lifetime
- 1999-06-24 EP EP99926783A patent/EP1090924B8/en not_active Expired - Lifetime
- 1999-06-25 TW TW088110697A patent/TWI228128B/zh not_active IP Right Cessation
-
2004
- 2004-12-03 HK HK04109605A patent/HK1067645A1/xx not_active IP Right Cessation
-
2005
- 2005-09-16 US US11/227,238 patent/US7368107B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010053180A (ko) | 2001-06-25 |
| EP1090924A4 (en) | 2002-07-10 |
| AU749544B2 (en) | 2002-06-27 |
| EP1090924B8 (en) | 2007-11-21 |
| JP4413429B2 (ja) | 2010-02-10 |
| DE69937294T2 (de) | 2008-07-03 |
| CN1318447C (zh) | 2007-05-30 |
| DE69937294D1 (de) | 2007-11-22 |
| WO1999067288A9 (fr) | 2000-03-30 |
| CA2331761A1 (en) | 1999-12-29 |
| WO1999067288A1 (fr) | 1999-12-29 |
| KR100653590B1 (ko) | 2006-12-04 |
| US20060008463A1 (en) | 2006-01-12 |
| TWI228128B (en) | 2005-02-21 |
| EP1090924B1 (en) | 2007-10-10 |
| ES2294844T3 (es) | 2008-04-01 |
| ATE375362T1 (de) | 2007-10-15 |
| US7368107B2 (en) | 2008-05-06 |
| EP1090924A1 (en) | 2001-04-11 |
| NZ508996A (en) | 2003-09-26 |
| US7041297B1 (en) | 2006-05-09 |
| HK1067645A1 (en) | 2005-04-15 |
| CN1525980A (zh) | 2004-09-01 |
| AU4392699A (en) | 2000-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID27788A (id) | Peptida-peptida antigen tumor yang diperoleh dari siklofilin b | |
| EP2022800A3 (en) | Compositions for the therapy and diagnosis of ovarian cancer | |
| DE69738754D1 (de) | Hemmer der interaktion zwischen p53 und mdm2 | |
| IL125590A (en) | Peptide immunogens, process for their preparation and use thereof as vaccines against allergies | |
| BR9907259A (pt) | Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu uso | |
| NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
| BR9908823A (pt) | Compostos e processos para terapia e diagnóstico de câncer de pulmão | |
| DE60239707D1 (de) | Antimikrobielle kationische peptide und diese enthaltende formulierungen | |
| WO2000078344A8 (en) | Prion protein peptides and uses thereof | |
| AU2001235006A1 (en) | Prophylactic and therapeutic monoclonal antibodies | |
| WO2000061756A3 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
| EP1762620A3 (en) | Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof | |
| WO1997018790A3 (en) | Therapeutic and diagnostic agents for the treatment of microbial infections | |
| NZ510154A (en) | A tumour antigen protein and gene therefor, tumour antigen peptides and derivatives thereof in medicaments and prophylactics | |
| EP1364657A4 (en) | REMEDIES AGAINST TUMORS AFFECTING HEMATOPOIETIC BODIES | |
| WO2003004517A3 (en) | Peyers's patch and/or m-celle targeting ligands | |
| NZ331398A (en) | Tumor rejection antigens presented by hla-b44 molecules, and uses thereof | |
| WO2004047757A3 (en) | Diagnosing and treating hematopoietic cancers | |
| WO2001029220A3 (en) | Mage-a12 antigenic peptides and uses thereof | |
| DE50114335D1 (de) | Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel | |
| WO2000052045A3 (en) | Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof | |
| WO2002066492A3 (fr) | Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques. | |
| ID27162A (id) | Peptida antigen tumor yang dibatasi hla-a2 yang berasal dari sart-1 | |
| WO2001019850A3 (en) | Nrage nucleic acids and polypeptides and uses thereof | |
| CY1108790T1 (el) | Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου |